Antinociceptive effect and enzymatic degradation of endomorphin-1 in newborn rat spinal cord

Japanese Journal of Pharmacology

Volumn 81, Issue 3, 1999, Pages 264-270

  Sugimoto Watanabe, Azusa ^a   Kubota, Kazufumi ^a   Fujibayashi, Kenji ^a   Saito, Koji ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

Endomorphin 1 and 2; Enkephalin; Enzymatic degradation; Slow ventral root potential; Spinal cord

Indexed keywords

ACTINONIN; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ENDOMORPHIN 1; ENDOMORPHIN 2; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; LEUCINE ENKEPHALIN; MORPHINE; MU OPIATE RECEPTOR; PEPTIDASE; THIORPHAN;

ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGRADATION; FEMALE; MALE; NERVE POTENTIAL; NEWBORN; NONHUMAN; RAT; SPINAL CORD; TISSUE HOMOGENATE; VENTRAL ROOT;

ANIMALS; ANIMALS, NEWBORN; BINDING, COMPETITIVE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, LEUCINE; FEMALE; HYDROLYSIS; MEMBRANE POTENTIALS; OLIGOPEPTIDES; PREGNANCY; PROTEASE INHIBITORS; RATS; RATS, WISTAR; SPINAL CORD;

EID: 0032794387     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.81.264     Document Type: Article

References (26)

1. Zadina JE, Hackler L, Ge LJ and Kastin AJ: A potent and selective endogenous agonist for the μ-opiate receptor. Nature 386, 499-502 (1997)
2. Martin-Schild S, Zadina JE, Gerall AA, Vigh S and Kastin AJ: Localization of endomorphin-2-like immunoreactivity in the rat medulla and spinal cord. Peptides 18, 1641-1649 (1997)
3. Pierce TL, Grahek MD and Wessendorf MW: Immunoreactivity for endomorphin-2 occurs in primary afferents in rats and monkey. Neuroreport 9, 385-389 (1998)
4. Schreff M, Schulz S, Wiborny D and Höllt V: Immunofluorescent identification of endomorphin-2-containing nerve fibers and terminals in the rat brain and spinal cord. Neuroreport 9, 1031-1034 (1998)
5. Stone LS, Fairbanks CA, Laughlin TM, Nguyen HO, Bushy TM, Wessendorf MW and Wilcox GL: Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2. Neuroreport 8, 3131-3135 (1997)
6. Goldberg IE, Rossi GC, Letchworth SR, Mathis JP, Ryan-Moro J, Leventhal L, Su W, Emmel D, Bolan EA and Pasternak GW: Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. J Pharmacol Exp Ther 286, 1007-1013 (1998)
7. Yamaguchi T, Kitagawa K and Kuraishi Y: Itch-associated response and antinociception induced by intracisternal endomorphins in mice. Jpn J Pharmacol 78, 337-343 (1998)
8. Akagi H, Konishi S, Otsuka M and Yanagisawa M: The role of substance P as a neurotransmitter in the reflexes of slow time courses in the neonatal rat spinal cord. Br J Pharmacol 84, 663-673 (1985)
9. Yanagisawa M, Murakoshi T, Tamai S and Otsuka M: Tailpinch method in vitro and the effects of some antinociceptive compounds. Eur J Pharmacol 106, 231-239 (1985)
10. Beruck M and Marks N: Enzymatic inactivation of substance P by a partially purified enzyme from rat brain. Biochem Biophys Res Commun 65, 153-160 (1975)
11. 5J-enkephalin hydrolysis in ileal and striatal preparations of guinea-pig: almost complete protection of degradation by the combination of amastatin, captopril and thiorphan. Jpn J Pharmacol 41, 437-446 (1986)
12. Matsas R, Kenny AJ and Turner AJ: The metabolism of neuropeptides. Biochem J 223, 433-440 (1984)
13. Otsuka M and Konishi S: Electrophysiology of mammalian spinal cord in vitro. Nature 252, 733-734 (1974)
14. 1 receptor antagonist, on a primary afferent-evoked response of ventral roots in the neonatal rat spinal cord. Br J Pharmacol 113, 1141-1146 (1994)
15. 1 receptor antagonist, in the isolated spinal cord of the neonatal rat. Eur J Pharmacol 281, 49-54 (1995)
16. Craves FB, Law PY, Hunt CA and Loh HH: The metabolic disposition of radiolabeled enkephalins in vitro and in situ. J Pharmacol Exp Ther 206, 492-506 (1978)
17. Chapman V, Diaz A and Dickenson AH: Distinct inhibitory effects of spinal endomorphin-1 and endomorphin-2 on evoked dorsal horn neuronal responses in the rat. Br J Pharmacol 122, 1537-1539 (1997)
18. 35S]GTPγS binding in rat brain: evidence for partial agonist activity at μ-opioid receptors. J Neurochem 70, 1567-1576 (1998)
19. 35S]GTPγS binding in the mouse spinal cord. Eur J Pharmacol 351, 383-387 (1998)
20. Hosohata K, Burkey TH, Alfaro-Lopez J, Varga E, Hruby VJ, Roeske WR and Yamamura HI: Endomorphin-1 and endomorphin-2 are partial agonists at the human μ-opioid receptor. Eur J Pharmacol 346, 111-114 (1998)
21. 35S]thio) triphosphate binding by endogenous opioids acting at a cloned mu receptor. J Pharmacol Exp Ther 286, 282-288 (1998)
22. Gong J, Strong JA, Zhang S, Yue X, DeHaven RN, Daubert JD, Cassel JA, Yu G, Mansson E and Yu L: Endomorphins fully activate a cloned human mu opioid receptor. FEBS Lett 439, 152-156 (1998)
23. Suzuki H, Yanagisawa M, Yoshioka K, Hosoki R and Otsuka M: Enzymatic inactivation of enkephalin neurotransmitters in the spinal cord of the neonatal rat. Neurosci Res 28, 261-267 (1997)
24. Hachisu M, Hiranuma T, Shibazaki Y, Uotani K, Murata S, Aoyagi T and Umezawa H: Composite effects of actinonin when inhibiting enkephalin-degrading enzymes. Eur J Pharmacol 137, 59-65 (1987)
25. Hachisu M, Hiranuma T, Murata S, Aoyagi T and Umezawa H: Analgesic effect of actinonin, a new potent inhibitor of multiple enkephalin degrading enzymes. Life Sci 41, 235-240 (1987)
26. Shane R, Wilk S and Bodnar RJ: Modulation of endomorphin-2-induced analgesia by dipeptidyl peptidase IV. Brain Res 815, 278-286 (1999)